February 13, 20192 min read, 391 words
Published: February 13, 2019 | 2 min read, 391 words
ShareMDMA, the principal ingredient in the party drug ecstasy, is about to give a lifeline to some of the worst sufferers of post-traumatic stress disorder (PTSD) in Israel—and the U.S. could be just years behind in launching similar clinical treatments using the substance.Israel...
CRITIC REVIEWS
There don't seem to be any reviews yet.
PUBLIC REVIEWS
There don't seem to be any reviews yet.